Selected research
Industry Research
Glucuronolactone Industry Research Report 2026
Market perspective
The global Glucuronolactone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Glucuronolactone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Glucuronolactone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Glucuronolactone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Glucuronolactone include Suzhou Pharmaceutical Group, Shaoxing Marina Biotechnology, Hubei Yitai Pharmaceutical, Anhui Fubore Pharmaceutical & Chemical, Shouguang Zhonghe Biochemical, Merck Millipore, Foodchem International, Creative Compounds and Ceto Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Glucuronolactone market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Glucuronolactone Market by Company
Suzhou Pharmaceutical Group
Shaoxing Marina Biotechnology
Hubei Yitai Pharmaceutical
Anhui Fubore Pharmaceutical & Chemical
Shouguang Zhonghe Biochemical
Merck Millipore
Foodchem International
Creative Compounds
Ceto Corporation
Glucuronolactone Segment by Type
Medical
Food
Glucuronolactone Segment by Application
Pharmaceuticals
Food & Beverage
Glucuronolactone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucuronolactone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Glucuronolactone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucuronolactone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Glucuronolactone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Glucuronolactone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Glucuronolactone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical
- Food
Applications
- Pharmaceuticals
- Food & Beverage
Companies covered
- Suzhou Pharmaceutical Group
- Shaoxing Marina Biotechnology
- Hubei Yitai Pharmaceutical
- Anhui Fubore Pharmaceutical & Chemical
- Shouguang Zhonghe Biochemical
- Merck Millipore
- Foodchem International
- Creative Compounds
- Ceto Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Glucuronolactone Market Size (2021-2032)
- 2.2.2 Global Glucuronolactone Sales (2021-2032)
- 2.2.3 Global Glucuronolactone Market Average Price (2021-2032)
- 2.3 Glucuronolactone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medical
- 2.3.3 Food
- 2.4 Glucuronolactone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceuticals
- 2.4.3 Food & Beverage
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Glucuronolactone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Glucuronolactone Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Glucuronolactone Revenue of Manufacturers (2021-2026)
- 3.4 Global Glucuronolactone Average Price by Manufacturers (2021-2026)
- 3.5 Global Glucuronolactone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Glucuronolactone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Glucuronolactone, Product Type & Application
- 3.8 Global Manufacturers of Glucuronolactone, Established Date
- 3.9 Global Glucuronolactone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Suzhou Pharmaceutical Group
- 4.1.1 Suzhou Pharmaceutical Group Company Information
- 4.1.2 Suzhou Pharmaceutical Group Business Overview
- 4.1.3 Suzhou Pharmaceutical Group Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Suzhou Pharmaceutical Group Glucuronolactone Product Portfolio
- 4.1.5 Suzhou Pharmaceutical Group Recent Developments
- 4.2 Shaoxing Marina Biotechnology
- 4.2.1 Shaoxing Marina Biotechnology Company Information
- 4.2.2 Shaoxing Marina Biotechnology Business Overview
- 4.2.3 Shaoxing Marina Biotechnology Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shaoxing Marina Biotechnology Glucuronolactone Product Portfolio
- 4.2.5 Shaoxing Marina Biotechnology Recent Developments
- 4.3 Hubei Yitai Pharmaceutical
- 4.3.1 Hubei Yitai Pharmaceutical Company Information
- 4.3.2 Hubei Yitai Pharmaceutical Business Overview
- 4.3.3 Hubei Yitai Pharmaceutical Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hubei Yitai Pharmaceutical Glucuronolactone Product Portfolio
- 4.3.5 Hubei Yitai Pharmaceutical Recent Developments
- 4.4 Anhui Fubore Pharmaceutical & Chemical
- 4.4.1 Anhui Fubore Pharmaceutical & Chemical Company Information
- 4.4.2 Anhui Fubore Pharmaceutical & Chemical Business Overview
- 4.4.3 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Anhui Fubore Pharmaceutical & Chemical Glucuronolactone Product Portfolio
- 4.4.5 Anhui Fubore Pharmaceutical & Chemical Recent Developments
- 4.5 Shouguang Zhonghe Biochemical
- 4.5.1 Shouguang Zhonghe Biochemical Company Information
- 4.5.2 Shouguang Zhonghe Biochemical Business Overview
- 4.5.3 Shouguang Zhonghe Biochemical Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shouguang Zhonghe Biochemical Glucuronolactone Product Portfolio
- 4.5.5 Shouguang Zhonghe Biochemical Recent Developments
- 4.6 Merck Millipore
- 4.6.1 Merck Millipore Company Information
- 4.6.2 Merck Millipore Business Overview
- 4.6.3 Merck Millipore Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merck Millipore Glucuronolactone Product Portfolio
- 4.6.5 Merck Millipore Recent Developments
- 4.7 Foodchem International
- 4.7.1 Foodchem International Company Information
- 4.7.2 Foodchem International Business Overview
- 4.7.3 Foodchem International Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Foodchem International Glucuronolactone Product Portfolio
- 4.7.5 Foodchem International Recent Developments
- 4.8 Creative Compounds
- 4.8.1 Creative Compounds Company Information
- 4.8.2 Creative Compounds Business Overview
- 4.8.3 Creative Compounds Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Creative Compounds Glucuronolactone Product Portfolio
- 4.8.5 Creative Compounds Recent Developments
- 4.9 Ceto Corporation
- 4.9.1 Ceto Corporation Company Information
- 4.9.2 Ceto Corporation Business Overview
- 4.9.3 Ceto Corporation Glucuronolactone Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ceto Corporation Glucuronolactone Product Portfolio
- 4.9.5 Ceto Corporation Recent Developments
5 Global Glucuronolactone Market Scenario by Region
- 5.1 Global Glucuronolactone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Glucuronolactone Sales by Region: 2021-2032
- 5.2.1 Global Glucuronolactone Sales by Region: 2021-2026
- 5.2.2 Global Glucuronolactone Sales by Region: 2027-2032
- 5.3 Global Glucuronolactone Revenue by Region: 2021-2032
- 5.3.1 Global Glucuronolactone Revenue by Region: 2021-2026
- 5.3.2 Global Glucuronolactone Revenue by Region: 2027-2032
- 5.4 North America Glucuronolactone Market Facts & Figures by Country
- 5.4.1 North America Glucuronolactone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Glucuronolactone Sales by Country (2021-2032)
- 5.4.3 North America Glucuronolactone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Glucuronolactone Market Facts & Figures by Country
- 5.5.1 Europe Glucuronolactone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Glucuronolactone Sales by Country (2021-2032)
- 5.5.3 Europe Glucuronolactone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Glucuronolactone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Glucuronolactone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Glucuronolactone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Glucuronolactone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Glucuronolactone Market Facts & Figures by Country
- 5.7.1 South America Glucuronolactone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Glucuronolactone Sales by Country (2021-2032)
- 5.7.3 South America Glucuronolactone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Glucuronolactone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Glucuronolactone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Glucuronolactone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Glucuronolactone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Glucuronolactone Sales by Type (2021-2032)
- 6.1.1 Global Glucuronolactone Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Glucuronolactone Sales Market Share by Type (2021-2032)
- 6.2 Global Glucuronolactone Revenue by Type (2021-2032)
- 6.2.1 Global Glucuronolactone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Glucuronolactone Revenue Market Share by Type (2021-2032)
- 6.3 Global Glucuronolactone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Glucuronolactone Sales by Application (2021-2032)
- 7.1.1 Global Glucuronolactone Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Glucuronolactone Sales Market Share by Application (2021-2032)
- 7.2 Global Glucuronolactone Revenue by Application (2021-2032)
- 7.2.1 Global Glucuronolactone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Glucuronolactone Revenue Market Share by Application (2021-2032)
- 7.3 Global Glucuronolactone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Glucuronolactone Value Chain Analysis
- 8.1.1 Glucuronolactone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Glucuronolactone Production Mode & Process
- 8.2 Glucuronolactone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Glucuronolactone Distributors
- 8.2.3 Glucuronolactone Customers
9 Global Glucuronolactone Analyzing Market Dynamics
- 9.1 Glucuronolactone Industry Trends
- 9.2 Glucuronolactone Industry Drivers
- 9.3 Glucuronolactone Industry Opportunities and Challenges
- 9.4 Glucuronolactone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst